SMS Lifesciences India Management
Management criteria checks 3/4
SMS Lifesciences India's CEO is Talluri Veera Venkata Murthy, appointed in Jun 2017, has a tenure of 7.5 years. total yearly compensation is ₹20.28M, comprised of 97.6% salary and 2.4% bonuses, including company stock and options. directly owns 23.86% of the company’s shares, worth ₹868.07M. The average tenure of the management team and the board of directors is 7.5 years and 3.8 years respectively.
Key information
Talluri Veera Venkata Murthy
Chief executive officer
₹20.3m
Total compensation
| CEO salary percentage | 97.6% |
| CEO tenure | 7.5yrs |
| CEO ownership | 23.9% |
| Management average tenure | 7.5yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
Earnings Working Against SMS Lifesciences India Limited's (NSE:SMSLIFE) Share Price Following 25% Dive
Nov 14
Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified
Aug 27Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Aug 01SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Jun 13SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump
Jan 05Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?
Sep 23SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50
Sep 07SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50
Aug 24SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 16SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 02SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt
Jun 03With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting
May 13SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals
Nov 23Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?
Jun 21Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Feb 22SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 04Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares
Nov 27Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?
Nov 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹219m |
| Jun 30 2024 | n/a | n/a | ₹179m |
| Mar 31 2024 | ₹20m | ₹20m | ₹91m |
| Dec 31 2023 | n/a | n/a | ₹49m |
| Sep 30 2023 | n/a | n/a | ₹46m |
| Jun 30 2023 | n/a | n/a | ₹67m |
| Mar 31 2023 | ₹20m | ₹20m | ₹115m |
| Dec 31 2022 | n/a | n/a | ₹189m |
| Sep 30 2022 | n/a | n/a | ₹172m |
| Jun 30 2022 | n/a | n/a | ₹247m |
| Mar 31 2022 | ₹20m | ₹18m | ₹253m |
| Dec 31 2021 | n/a | n/a | ₹213m |
| Sep 30 2021 | n/a | n/a | ₹216m |
| Jun 30 2021 | n/a | n/a | ₹147m |
| Mar 31 2021 | ₹24m | n/a | ₹136m |
| Dec 31 2020 | n/a | n/a | ₹106m |
| Sep 30 2020 | n/a | n/a | ₹76m |
| Jun 30 2020 | n/a | n/a | ₹79m |
| Mar 31 2020 | ₹24m | ₹20m | ₹102m |
Compensation vs Market: Talluri Veera Venkata's total compensation ($USD238.38K) is above average for companies of similar size in the Indian market ($USD42.37K).
Compensation vs Earnings: Talluri Veera Venkata's compensation has been consistent with company performance over the past year.
CEO
Talluri Veera Venkata Murthy (64 yo)
7.5yrs
Tenure
₹20,277,686
Compensation
Mr. Talluri Veera Venkata Satyanarayana Murthy had been a Non-Executive Director at SMS Pharmaceuticals Limited since 2019 until May 28, 2021. Mr. Murthy serves as Managing Director of SMS Lifesciences Ind...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | 7.5yrs | ₹20.28m | 23.86% ₹ 868.1m | |
| CFO & GM of Accounts / Finance | 7.5yrs | ₹1.94m | no data | |
| Company Secretary & Compliance Officer | 4.8yrs | ₹1.24m | no data | |
| Chief Marketing Officer & Executive Director | 7.5yrs | ₹7.20m | 4.37% ₹ 159.1m | |
| Whole-Time Director | no data | ₹2.40m | 2.61% ₹ 95.0m | |
| General Manager of Operations | no data | no data | no data | |
| Manager of Admin/HR/IT | no data | no data | no data |
7.5yrs
Average Tenure
52.5yo
Average Age
Experienced Management: SMSLIFE's management team is seasoned and experienced (7.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | 8.7yrs | ₹20.28m | 23.86% ₹ 868.1m | |
| Chief Marketing Officer & Executive Director | 4.3yrs | ₹7.20m | 4.37% ₹ 159.1m | |
| Whole-Time Director | 3.3yrs | ₹2.40m | 2.61% ₹ 95.0m | |
| Non-Executive & Independent Director | 7.6yrs | ₹445.00k | 0.10% ₹ 3.7m | |
| Non-Executive Independent Director | 3.1yrs | ₹460.00k | no data | |
| Non-Executive Independent Director | 3.1yrs | ₹195.00k | no data |
3.8yrs
Average Tenure
64yo
Average Age
Experienced Board: SMSLIFE's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 11:37 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SMS Lifesciences India Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kameswari V. S. Chavali | FirstCall Research |